SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as institutional ownership by major firms continues to surge, fueling active community speculation regarding an imminent buyout or positive data from the REGAL clinical trial. Investors are closely monitoring the status of the 80th trial event, with many debating the impact of upcoming filings and the potential for a market-moving catalyst as the company approaches its next earnings report.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is currently a focal point for investors as its subsidiary Sentrycs secures high-profile counter-drone security contracts, including a deal to protect Jacksonville Jaguars home games at EverBank Stadium. The community is actively discussing the stock's potential for a short squeeze ahead of upcoming earnings, highlighting a heavy short interest, a wave of recent defense contract wins, and significant institutional accumulation as catalysts for a potential move toward double-digit pricing.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera is currently trending as investors focus on the upcoming Phase 2 top-line data readout for ABCL635, a potential first-in-class treatment for menopause-related symptoms. The community is actively debating the company's ability to validate its AI-assisted drug discovery platform while monitoring high short interest and institutional accumulation, leading to intense speculation regarding the potential for a short squeeze.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors focus on the company's transformation into an AI infrastructure player following its Northern Data acquisition and strategic cloud deals, while community sentiment remains split between bullish anticipation of an earnings breakout and skepticism over current price action. Discussion is currently dominated by high short interest and the belief that the stock is significantly undervalued compared to the potential revenue growth from newly acquired data centers and GPUs.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending as investors debate whether the recent consolidation marks a definitive bottom or a pause before a larger breakout, with sentiment heavily influenced by broader macroeconomic factors like interest rate expectations and the geopolitical landscape. The community remains focused on silver's critical role in AI infrastructure and industrial demand, while actively monitoring the stock's price action against key support levels and upcoming Fed developments.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is trending as investors weigh its strong Q1 operational performance against potential headwinds from its Pakistan-based Reko Diq project. The community remains focused on the company's ability to navigate geopolitical risks while capitalizing on elevated gold prices through increased production and a new $3 billion share buyback program.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund is experiencing heightened volatility and intense community debate as investors weigh near-term geopolitical risks against a complex, evolving diplomatic framework involving the Strait of Hormuz. While some participants are positioning for a potential long-term infrastructure and production shift, others remain focused on the impact of ongoing supply uncertainty and energy policy volatility.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is capturing significant investor attention following the launch of its new venture fund and ongoing community discussion around its aggressive expansion into blockchain and tokenized asset services. Traders are actively debating whether the stock's recent volatility represents a structural shift or a prime entry point as technical indicators like the Golden Cross and various breakout levels become focal points for bullish sentiment.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing a powerful surge driven by strong institutional accumulation and a blowout earnings report that shattered growth expectations. The community is buzzing with bullish sentiment, with many investors focused on the company's expanding enterprise AI adoption and sovereign defense contracts as catalysts for long-term growth despite vocal skepticism from short sellers.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is trending due to heightened community interest in its high-speed optical networking technology, which is viewed as a critical bottleneck for expanding AI data center infrastructure. Investors are closely tracking the company's manufacturing capacity expansion and potential benefits from proposed policies regarding domestic optical supply chains ahead of the upcoming earnings release.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MoonLake Immunotherapeutics is facing intense community speculation regarding the timing of its Phase 3 IZAR-1 trial results, with investors closely watching for a potential earnings-linked announcement or data release ahead of upcoming industry conferences. While community members remain divided over the specific timing and management's communication, the overarching sentiment is driven by anticipation that Best-in-Class data could trigger a significant re-rating or ignite strategic M&A interest.

MLTX Stock Under Pressure As Investors Await Psoriatic Arthritis Trial Data  

Equity

MoonLake has consistently guided for a “mid-2026” primary endpoint readout from IZAR-1, its late-stage trial for sonelokimab in certain patients with active psoriatic arthritis. 


Wall Street Analysts See a 73.35% Upside in MOONLAKE IMMUNO (MLTX): Can the Stock Really Move This High?

The consensus price target hints at a 73.4% upside potential for MOONLAKE IMMUNO (MLTX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

SLS Vs MLTX: Retail Traders Race To Pick Merck’s Next Biotech Buyout As Keytruda’s $31.7B Patent Cliff Nears

SLS leads in stock momentum, while MLTX is cheaper and better-funded, with nearly $300 million in cash at the end of the first quarter.

MoonLake Immunotherapeutics' CFO Sells 39K Shares

Key PointsThe executive sold 39,120 shares on June 22...

MoonLake Immunotherapeutics (MLTX) Outlook Strengthens as Analysts See Major Opportunity in Hidradenitis Suppurativa

MoonLake Immunotherapeutics (MLTX) Outlook Strengthens as Analysts See Major Opportunity in Hidradenitis Suppurativa...

Why MoonLake Immunotherapeutics Stock Wilted on Wednesday

Key PointsIt aims to raise up to $200 million in the offering...

MLTX Stock Extends Pullback After Biggest Rally In Over 6 Months Following Skin Disease Trial Data — A Look At The Latest Development

The biotech firm upsized its offering to $200 million, up from the previously announced $150 million.

MLTX Stock Clocks Best Day In Over 6 Months — What’s Driving The Investor Optimism? 

Clear Street described sonelokimab’s profile in hidradenitis suppurativa as highly competitive and one that readily supports “blockbuster potential.”


Why Is MoonLake Immunotherapeutics Stock Soaring Monday?

MoonLake reported durable one-year Phase 3 hidradenitis suppurativa data for sonelokimab and plans an FDA filing in September 2026.read more...

S&P 500, Nasdaq, Dow Futures Slip After Trump Warns Iran Of Fresh Strikes Over Hormuz Standoff: INTC, MLTX, SNDK, KEEL In Focus

Iran argued that Washington had failed to uphold commitments to curb hostilities in Lebanon. 

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

MoonLake Immunotherapeutics

Investors are on high alert for mandatory Q2 earnings and pivotal IZAR-1 trial results due by August 10th.

Speculation intensifies over a potential multi-billion dollar acquisition by major strategic partners like Merck.

Hopes are pinned on sonelokimab achieving superior efficacy and disease-modifying data compared to current competitors.

Feed

News

Sentiment

Earnings

Fundamentals

Info

MLTXMoonLake Immunotherapeutics

Fundamentals

Connect Stocktwits to ChatGPT

Latest MLTX News